U.S. market projected to hit USD 2.56 billion and Europe market estimated to reach USD 2.42 billion by 2035 as demand for bone graft substitutes and regenerative technologies accelerates. U.S. market projected to hit USD 2.56 billion and Europe market estimat…
The cell banking outsourcing market is witnessing strong growth driven by increasing demand for biologics, rising adoption of cell and gene therapies, and growing investment in regenerative medicine and biopharmaceutical research. North America currently lead…
The Diabetic Neuropathy Management market is poised for growth, driven by rising demand for early diagnosis, novel therapies, and integrated care approaches The Diabetic Neuropathy Management market is poised for growth, driven by rising demand for early diag…